Amedeo Smart

Free Medical Literature Service


 

Amedeo

Influenza

  Free Subscription

Articles published in
J Exp Med
    January 2022
  1. MAO T, Israelow B, Lucas C, Vogels CBF, et al
    A stem-loop RNA RIG-I agonist protects against acute and chronic SARS-CoV-2 infection in mice.
    J Exp Med. 2022;219.
    >> Share

    December 2021
  2. SHINNAKASU R, Sakakibara S, Yamamoto H, Wang PH, et al
    Glycan engineering of the SARS-CoV-2 receptor-binding domain elicits cross-neutralizing antibodies for SARS-related viruses.
    J Exp Med. 2021;218.
    >> Share

  3. LU X, Hosono Y, Nagae M, Ishizuka S, et al
    Identification of conserved SARS-CoV-2 spike epitopes that expand public cTfh clonotypes in mild COVID-19 patients.
    J Exp Med. 2021;218.
    >> Share

    November 2021
  4. RAPPE JCF, Finsterbusch K, Crotta S, Mack M, et al
    A TLR7 antagonist restricts interferon-dependent and -independent immunopathology in a mouse model of severe influenza.
    J Exp Med. 2021;218.
    >> Share

    October 2021
  5. DECKER T
    The early interferon catches the SARS-CoV-2.
    J Exp Med. 2021;218.
    >> Share

  6. LOPEZ J, Mommert M, Mouton W, Pizzorno A, et al
    Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs.
    J Exp Med. 2021;218.
    >> Share

    September 2021
  7. AHN M, Wang LF
    Translation from bats to humans beyond infectious diseases.
    J Exp Med. 2021;218.
    >> Share

    August 2021
  8. CHEEMARLA NR, Watkins TA, Mihaylova VT, Wang B, et al
    Dynamic innate immune response determines susceptibility to SARS-CoV-2 infection and early replication kinetics.
    J Exp Med. 2021;218.
    >> Share

  9. WILK AJ, Lee MJ, Wei B, Parks B, et al
    Multi-omic profiling reveals widespread dysregulation of innate immunity and hematopoiesis in COVID-19.
    J Exp Med. 2021;218.
    >> Share

    July 2021
  10. BASTARD P, Orlova E, Sozaeva L, Levy R, et al
    Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1.
    J Exp Med. 2021;218.
    >> Share

  11. SOLFOROSI L, Kuipers H, Jongeneelen M, Rosendahl Huber SK, et al
    Immunogenicity and efficacy of one and two doses of Ad26.COV2.S COVID vaccine in adult and aged NHP.
    J Exp Med. 2021;218.
    >> Share

    June 2021
  12. LANZ C, Schotsaert M, Magnus C, Karakus U, et al
    IFITM3 incorporation sensitizes influenza A virus to antibody-mediated neutralization.
    J Exp Med. 2021;218.
    >> Share

  13. SANCHO-SHIMIZU V, Brodin P, Cobat A, Biggs CM, et al
    SARS-CoV-2-related MIS-C: A key to the viral and genetic causes of Kawasaki disease?
    J Exp Med. 2021;218.
    >> Share

    May 2021
  14. ANDREANO E, Rappuoli R
    Immunodominant antibody germlines in COVID-19.
    J Exp Med. 2021;218.
    >> Share

  15. LE BERT N, Clapham HE, Tan AT, Chia WN, et al
    Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection.
    J Exp Med. 2021;218.
    >> Share

  16. MERAD M, Vabret N
    Highlights from a year in a pandemic.
    J Exp Med. 2021;218.
    >> Share

  17. BAUM A, Kyratsous CA
    SARS-CoV-2 spike therapeutic antibodies in the age of variants.
    J Exp Med. 2021;218.
    >> Share

  18. KEDL RM
    Down but far from out: The durability of SARS-CoV-2 immunity after asymptomatic infection.
    J Exp Med. 2021;218.
    >> Share

    April 2021
  19. ZHUANG Z, Lai X, Sun J, Chen Z, et al
    Mapping and role of T cell response in SARS-CoV-2-infected mice.
    J Exp Med. 2021;218.
    >> Share

  20. ONODI F, Bonnet-Madin L, Meertens L, Karpf L, et al
    SARS-CoV-2 induces human plasmacytoid predendritic cell diversification via UNC93B and IRAK4.
    J Exp Med. 2021;218.
    >> Share

  21. BRETON G, Mendoza P, Hagglof T, Oliveira TY, et al
    Persistent cellular immunity to SARS-CoV-2 infection.
    J Exp Med. 2021;218.
    >> Share

  22. BASTARD P, Michailidis E, Hoffmann HH, Chbihi M, et al
    Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine.
    J Exp Med. 2021;218.
    >> Share

  23. POON MML, Farber DL
    Lasting memories of SARS-CoV-2 infection.
    J Exp Med. 2021;218.
    >> Share

  24. MCCARTY NA
    Breathe-Your immune system is counting on it.
    J Exp Med. 2021;218.
    >> Share

    March 2021
  25. SCHAFER A, Muecksch F, Lorenzi JCC, Leist SR, et al
    Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo.
    J Exp Med. 2021;218.
    >> Share

  26. LU Y, Jiang R, Freyn AW, Wang J, et al
    CD4+ follicular regulatory T cells optimize the influenza virus-specific B cell response.
    J Exp Med. 2021;218.
    >> Share

  27. RODRIGUES TS, de Sa KSG, Ishimoto AY, Becerra A, et al
    Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients.
    J Exp Med. 2021;218.
    >> Share

  28. BRYANT C
    COVID-19 stokes inflammasomes.
    J Exp Med. 2021;218.
    >> Share

  29. SONG E, Zhang C, Israelow B, Lu-Culligan A, et al
    Neuroinvasion of SARS-CoV-2 in human and mouse brain.
    J Exp Med. 2021;218.
    >> Share

  30. NIMMERJAHN F, Ravetch JV
    Four keys to unlock IgG.
    J Exp Med. 2021;218.
    >> Share

    January 2021
  31. PAIK DH, Farber DL
    Influenza infection fortifies local lymph nodes to promote lung-resident heterosubtypic immunity.
    J Exp Med. 2021;218.
    >> Share

    December 2020
  32. ISRAELOW B, Song E, Mao T, Lu P, et al
    Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling.
    J Exp Med. 2020;217.
    >> Share

  33. JOUAN Y, Guillon A, Gonzalez L, Perez Y, et al
    Phenotypical and functional alteration of unconventional T cells in severe COVID-19 patients.
    J Exp Med. 2020;217.
    >> Share

  34. VERAS FP, Pontelli MC, Silva CM, Toller-Kawahisa JE, et al
    SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology.
    J Exp Med. 2020;217.
    >> Share

  35. RADERMECKER C, Detrembleur N, Guiot J, Cavalier E, et al
    Neutrophil extracellular traps infiltrate the lung airway, interstitial, and vascular compartments in severe COVID-19.
    J Exp Med. 2020;217.
    >> Share

  36. MAJOR J, Wack A
    An ace model for SARS-CoV-2 infection.
    J Exp Med. 2020;217.
    >> Share

  37. KOAY HF, Fulford TS, Godfrey DI
    An unconventional view of COVID-19 T cell immunity.
    J Exp Med. 2020;217.
    >> Share

    November 2020
  38. SCHMIDT F, Weisblum Y, Muecksch F, Hoffmann HH, et al
    Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses.
    J Exp Med. 2020;217.
    >> Share

  39. SHUBINA M, Tummers B, Boyd DF, Zhang T, et al
    Necroptosis restricts influenza A virus as a stand-alone cell death mechanism.
    J Exp Med. 2020;217.
    >> Share

  40. KIM JH
    SARS-CoV-2 vaccine development, access, and equity.
    J Exp Med. 2020;217.
    >> Share

    October 2020
  41. CASSOTTA A, Paparoditis P, Geiger R, Mettu RR, et al
    Deciphering and predicting CD4+ T cell immunodominance of influenza virus hemagglutinin.
    J Exp Med. 2020;217.
    >> Share

  42. ZHOU T, Su TT, Mudianto T, Wang J, et al
    Immune asynchrony in COVID-19 pathogenesis and potential immunotherapies.
    J Exp Med. 2020;217.
    >> Share

    September 2020
  43. KOENIG LM, Boehmer DFR, Metzger P, Schnurr M, et al
    Blocking inflammation on the way: Rationale for CXCR2 antagonists for the treatment of COVID-19.
    J Exp Med. 2020;217.
    >> Share

  44. NATHAN C
    Neutrophils and COVID-19: Nots, NETs, and knots.
    J Exp Med. 2020;217.
    >> Share

  45. FREEDMAN TS, Headley MB, Serwas N, Ruhland M, et al
    Lessons of COVID-19: A roadmap for post-pandemic science.
    J Exp Med. 2020;217.
    >> Share

  46. HOUSTON S
    Lessons of COVID-19: Virtual conferences.
    J Exp Med. 2020;217.
    >> Share

    August 2020
  47. STOLLEY JM, Johnston TS, Soerens AG, Beura LK, et al
    Retrograde migration supplies resident memory T cells to lung-draining LN after influenza infection.
    J Exp Med. 2020;217.
    >> Share

  48. DIAMOND B
    The renin-angiotensin system: An integrated view of lung disease and coagulopathy in COVID-19 and therapeutic implications.
    J Exp Med. 2020;217.
    >> Share

    June 2020
  49. BARNES BJ, Adrover JM, Baxter-Stoltzfus A, Borczuk A, et al
    Targeting potential drivers of COVID-19: Neutrophil extracellular traps.
    J Exp Med. 2020;217.
    >> Share

  50. VARDHANA SA, Wolchok JD
    The many faces of the anti-COVID immune response.
    J Exp Med. 2020;217.
    >> Share

    May 2020
  51. NATHAN CF, Nussenzweig MC, Pulvirenti T
    We are here for you and ready to hear from you.
    J Exp Med. 2020;217.
    >> Share

  52. WEISS SR
    Forty years with coronaviruses.
    J Exp Med. 2020;217.
    >> Share

  53. PROKUNINA-OLSSON L, Alphonse N, Dickenson RE, Durbin JE, et al
    COVID-19 and emerging viral infections: The case for interferon lambda.
    J Exp Med. 2020;217.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016